Dr. Moussa, Bachelor of Medicine, Bachelor of Surgery, Ph.D., in Biomedical Sciences, is the Director of the GUMC Translational Neurotherapeutics Program and the Laboratory for Dementia and Parkinsonism. He is the Principal Investigator of the Lewy Body Disease Association Research Center of Excellence. His expertise is in geriatric neurology with special focus on movement and memory disorders, and he is a neuroscientist focused on autophagy. Dr. Moussa is a clinical trialist and a translational neuroscience investigator who has designed and completed a number of phase I-III trials in AD, PD, LBD and HD and generated several compounds known as tyrosine kinase inhibitors that can potentially be used as a therapy for neurodegenerative diseases. He discovered the potential use of cancer drugs, including nilotinib and bosutinib as a treatment for neurodegenerative diseases and identified a novel drug target known as discoidin domain receptor (DDR)-1 that can induce autophagic clearance of misfolded proteins in preclinical and clinical settings. Dr. Moussa is an expert on tyrosine kinase inhibitors and their promising effects on neurodegenerative pathologies. Dr. Moussa is published widely in peer reviewed scientific and medical journals on the mechanisms, diagnostics, and treatment of neurodegenerative diseases.
Dr. Fernando L. Pagan is the Vice Chairman and Professor in the Department of Neurology at Medstar Georgetown University Hospital. He received his medical degree from Georgetown University, completed an internal medicine internship and a Neurology residency at Georgetown University Hospital. Dr. Pagan completed a fellowship in Movement Disorders and Magnetic Resonance Spectroscopy at the National Institute of Neurological Diseases and Stroke. He is a board certified Neurologist. He is the director of the Movement Disorders Program and the Medical Director of the Medstar Georgetown University Hospital. National Parkinson Foundation Center of Excellence. Dr. Pagan serves as the fellowship director for the clinical research fellowship in movement disorders at Medstar Georgetown University Hospital, he has trained over 24 fellows in movement disorders. His special interests include Parkinson’s disease, parkinsonism and other related disorders, ataxia, essential tremor, dystonia and tics. He is a member of the functional neurosurgery team for movement disorders, performing preoperative evaluations and programming for deep brain stimulators in Parkinson’s disease, essential tremor and dystonia.
Dr. Pagan is the Medical director of the Georgetown University Medical Center Translational Neurotherapeutics Program (TNP) and has been the primary investigator of a number of clinical trials that are initiated by the TNP. Dr. Pagan has published widely in peer reviewed scientific and medical journals on the topic of Parkinson’s Disease and movement disorders.
Dr. Yasar Yaghi is the Principal Investigator for the Lewy Body Dementia Clinic and the Director of the Parkinsonism and Dementia Clinic at Medstar Georgetown University Hospital. He spearheads an initiative to care for a growing population of aging patients with neurodegenerative conditions. Dr. Yaghi obtained his medical degree from George Washington University School of Medicine and subsequently completed his residency and fellowship training at MedStar Georgetown University Hospital. He specializes in movement disorders and dementia, where he is an investigator in research, with specific training and expertise in Lewy body dementia and atypical Parkinsonism. Dr. Yaghi’s research focus is in neurodegeneration, and movement disorders such as Lewy body dementia, and Parkinson’s disease. Additionally, he evaluates patients with Alzheimer’s disease, chronic traumatic encephalopathy, and Huntington’s disease. Dr. Yaghi is published widely in peer reviewed scientific and medical journals on the topics of diagnosing and treating neurodegenerative diseases.
Pasha is vice president of business operations at KeifeRx. Prior to joining the KeifeRx team, Pasha was a Co-Founder of Heuristics Health, a medical device company focused on the field of vascular screening. Pasha received his Bachelor of Arts in Political Science from UCLA, his Master of Public Health from Columbia University, and his Juris Doctor from George Mason University School of Law. Pasha is a member of the D.C. Bar.
Andy is the leader of the Morgan Lewis’ interdisciplinary corporate practice in Washington, DC, where he represents public and private companies, financial sponsors, and management teams in a broad range of industries, including technology, financial services, life sciences, real estate, and the not-for-profit sector. He led the team representing Oculus VR in its $2 billion sale to Facebook. Andy is a board member or observer at BluLogix, entrée.ai, ExecVision, HealthSlate, LeaseAccelerator, and Pixelligent Technologies. Andy received his Bachelor of Arts from Georgetown University and a Masters of Arts and a Juris Doctor from Duke University.
Mike is the Chief Financial Officer of Apptek. Mike has more than 30 years of experience in leading the financial and accounting function of both large and small organizations. His background includes time as Vice President of Finance for Hamilton Sundstrand division of United Technologies Corporation; as CFO of an international joint-venture in Moscow Russia (HS-Nauka); as an Investment Manager for Defense Enterprise Fund an international venture capital fund; and more than 10 years experience in venture capital and private equity most recently with MCG Capital Corporation. During his career, Mike has been involved with over $450 million of financing or M&A transactions. Mike has a Bachelor of Science in Finance from the University of Connecticut and an MBA from the Rensselaer Polytechnic Institute.